Viapanase

A drug created and manufactured by Advancer Enterprises, it entered Advancer's pharmaceutical catalog in late YE 45. Viapanase is an anti-toxin medication designed to purge toxins trapped within the mucous lining of the respiratory system. It exists as a powder that must be inhaled.

Viapanase was conceptualized to address the escalating prevalence of respiratory ailments caused by environmental toxins, particularly in industrialized regions like Fujiko. Advancer Enterprises, recognizing the absence of a specialized respiratory anti-toxin, initiated a multi-disciplinary R&D program. The development involved collaborations with pulmonologists, toxicologists, and pharmacologists. Rigorous clinical trials were conducted to ascertain the drug's efficacy and safety. Upon receiving Imperial approval in late YE 45.

Viapanase operates by enzymatically breaking down toxins lodged in the mucous lining of the respiratory tract. This facilitates their neutralization and subsequent expulsion, either through coughing or metabolic processing. The drug is particularly effective against a range of industrial and environmental toxins, including heavy metals and volatile organic compounds.

The standard dosage for Viapanase is a single inhalation of 50 mg of the powdered drug, administered through a specialized inhaler. Each inhaler comes pre-loaded with 1000 mg of Viapanase, allowing for 20 doses per device. The drug is priced at 30 KS per inhaler. It is advised to limit usage to two inhalations within a 24-hour period to prevent potential side effects.

While Viapanase is generally well-tolerated, users may experience mild respiratory irritations such as coughing, sneezing, or nasal congestion. In rare instances, more severe side effects like shortness of breath, chest pain, or allergic reactions may occur. Chronic use of Viapanase can compromise the integrity of the mucous lining, making the respiratory system more susceptible to infections and irritations.

An overdose of Viapanase is defined as the inhalation of more than 125 mg within a 24-hour period. Excessive use can lead to the degradation of the mucous lining, increasing vulnerability to respiratory infections. Immediate medical intervention is crucial, often involving the administration of bronchodilators and corticosteroids to manage inflammation and restore normal respiratory function.

Demibear created this article on 2023/10/09 23:29.

Approval Thread: https://stararmy.com/roleplay-forum/threads/advancer-enterprises-white-lion-type-45-vehicle-aid-kit.71051/